Both assays are integrated with molecular bar-coding to provide automated quality-assurance testing. Vancouv...

Boston, USA, London, UK, and Martinsried, Germany, December 14, 2018 / B3C newswire / -- Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceut...

Cambridge, UK, 17 December 2018: Horizon Discovery Group plc (AIM: HZD), a global leader in the application of gene editing and gene modulation technologies, today an...

Irisin, the once much-hyped “exercise hormone,” could inspire new osteoporosis treatments, its discoverer said. (Pixab...

Under an FDA “Fast Track” designation, Idera has already pushed the tilsotolimod-Yervoy combo to phase 3 PD-1-refracto...

  Can CRISPR be used to treat obesity? In mice, at least, it seems possible. Researchers at UC San Franciscorecently publishedresearch in the journalScience ...

Gene therapy developer AGTC lost nearly half its market cap Thursday morning after Biogen exited a collaboration agreement on the heels of a big clinical failure....

Singapore, December 14, 2018 / B3C newswire / -- Prestige BioPharma (“Prestige”) announced today that it has reached a licensing agreement with Cipla Limited (“Cipla”...

Leiden, the Netherlands, December 11, 2018 / B3C newswire / -- Batavia Biosciences announces today that the International AIDS Vaccine Initiative (IAVI) and Batavia B...

New facility expected to create more than 100 new jobs, supporting extensive gene therapy pipeline Enhances Orchard’s capacity to develop and deliver lentiviral ...